CLINICAL_TRIALS ClinicalTrials.gov record update

Inhaled ZYESAMI™ for the Treatment of Severe COVID-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04360096
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:49.121385+00:00
Published At: 2023-02-03T00:00:00+00:00
Record Updated At: 2023-02-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["SARS-CoV 2", "COVID", "ARDS", "ALI", "Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)", "Dyspnea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-02-03"
protocolSection.identificationModule.nctId: "NCT04360096"
protocolSection.identificationModule.officialTitle: "Inhaled ZYESAMI\u2122 for the Treatment of Severe COVID-19"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.